Completed NA INTERVENTIONAL 2-arm NCT02533466

In Vivo Investigation of Initial Stages of Enamel Erosion

Study to Investigate the Initial Stages of Enamel Erosion in Vivo

Sponsor: GlaxoSmithKline

Interventions Potassium nitrate Sodium fluoride + potassium nitrate

Updated 8 times since 2017 Last updated: Jun 28, 2017 Started: Oct 1, 2015 Primary completion: Nov 6, 2015 Completion: Nov 6, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02533466, this NA trial focuses on Tooth Erosion and remains completed. Sponsored by GlaxoSmithKline, it has been updated 8 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2023 — Jul 2024 [monthly]

Completed NA
Dec 2022 — Jan 2023 [monthly]

Completed NA
Jan 2021 — Dec 2022 [monthly]

Completed NA

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed NA
Jul 2017 — Jun 2018 [monthly]

Completed NA
Jan 2017 — Jul 2017 [monthly]

Completed NA

First recorded

Oct 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

GlaxoSmithKline

Data source: GlaxoSmithKline

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bristol, United Kingdom